Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.
Press releases published on April 3, 2025
Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation to the U.S. Government’s …
Anne Whitaker Appointed as Non-Executive Director
GlobeNewswire
·
April 3, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker as a Non-Executive Director (NED) based in the United …
Praxis Precision Medicines to Participate in Upcoming April Conferences
GlobeNewswire
·
April 3, 2025
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 3, 2025
-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers -- -- Strengthened Balance Sheet through Sale of Excess Capital Equipment, Raising Approximately $17.0 Million -- …
Vaxil: Management and Operational Update
GlobeNewswire
·
April 3, 2025
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), is pleased to make the following updates regarding the Company’s activities, …
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
GlobeNewswire
·
April 3, 2025
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million upfront payment and expand dataset to combination therapy New interim data for the vebreltinib development …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 3, 2025
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Intersec fête ses 20 ans et revient sur le lancement de FR-Alert : L'innovation et l’IA au service de la sécurité
EIN Presswire
·
April 3, 2025
Dans un contexte où l’Europe cherche à renforcer sa souveraineté, la société propose aux ministères régaliens une large gamme d'applications innovantes. PARIS, FRANCE, April 3, 2025 /EINPresswire.com/ -- Intersec, leader mondial des solutions d’analyse …
Investico.com Implements Advanced Encryption Protocols to Secure Data
GlobeNewswire
·
April 3, 2025
JOHANNESBURG, South Africa, April 03, 2025 (GLOBE NEWSWIRE) -- Investico.com, a name in the financial industry, operated by Faraz Financial Services (PTY) Limited, offers CFD trading. As a company focused on financial solutions, it offers a range of tools …
BetterLife Pharma Appoints Corporate Advisor
GlobeNewswire
·
April 3, 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed André Beaudry as Corporate …
Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
GlobeNewswire
·
April 3, 2025
Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition affecting five to 12% of the population globally TMJ causes pain and stiffness in the jaw, making it …
Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome
GlobeNewswire
·
April 3, 2025
MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria Rare Pediatric Designation granted MNV-201 is also being studied in a Phase Ib for low-risk …
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
GlobeNewswire
·
April 3, 2025
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified …
GFG Announces C$2.5 Million Flow-Through Private Placement
GlobeNewswire
·
April 3, 2025
SASKATOON, Saskatchewan, April 03, 2025 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) announces a private placement of premium flow-through units ("Premium Units") to raise gross proceeds of up to C$2.5 million …
Guinean Artist Elie Kamano to Release New Single Exploring Africa's Colonial Past
GlobeNewswire
·
April 3, 2025
JOHANNESBURG, SOUTH AFRICA, April 03, 2025 (GLOBE NEWSWIRE) -- CAJ News Africa will host the official presentation of Guinean musician Elie Kamano's new single "Africa without Africans" on April 5, 2025, at the Johannesburg Arts Centre, the agency …